Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)

Mohammad   Amjad    Kamal; Eshak    I.    Bahbah

doi:10.2174/187152732008210921121240

« Previous Next »

Rights & Permissions Print Cite

CNS & Neurological Disorders - Drug Targets

Title:Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)

Volume: 20 Issue: 8

Author(s): Mohammad Amjad Kamal*Eshak I. Bahbah*

Affiliation:

King Fahd Medical Research Center King Abdulaziz University Jeddah,Saudi Arabia

Faculty of Medicine Al-Azhar University Damietta,Egypt

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Kamal Amjad Mohammad*, Bahbah I. Eshak *, Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II), CNS & Neurological Disorders - Drug Targets 2021; 20 (8) . https://dx.doi.org/10.2174/187152732008210921121240

DOI https://dx.doi.org/10.2174/187152732008210921121240	Print ISSN 1871-5273
Publisher Name Bentham Science Publisher	Online ISSN 1996-3181

About this journal

Call for Papers in Thematic Issues

Submission closes on : 07 January, 2025

Heart and Brain Axis Targets in CNS Neurological Disorders

Recently there has been a surge of interest in delving deeper into the complex interplay between the heart and brain. This fascination stems from a growing recognition of the profound influence each organ holds over the other, particularly in the realm of central nervous system (CNS) neurological disorders. The purpose ...read more

Guest Editor(s): Melis Olcum

Submission closes on : 01 January, 2025

Lifestyle Interventions to Prevent and Treat Cognitive Impairment and Dementia

More than 55 million people live with dementia worldwide. By 2050, the population affected by dementia will exceed 139 million individuals. Mild cognitive impairment (MCI) is a pre-dementia stage, also known as prodromal dementia, affecting older adults. MCI emerges years before the manifestation of dementia but can be avoidable and ...read more

Guest Editor(s): Dr. Renato Sobral Monteiro-Junior

Submission closes on : 08 December, 2024

Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities

The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more

Guest Editor(s): Dr. Nitish Bhatia